Gene therapy using circular forms of DNA called plasmids may help treat lung disease in cystic fibrosis (CF), based…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Trikafta was associated with significant reductions in healthcare use, including hospitalizations related to cystic…
Children with cystic fibrosis (CF) who undergo a liver transplant alone have significantly better survival rates than those who receive…
Both youngsters and teenagers with cystic fibrosis (CF) have abnormal levels of bile acids, the main components of the…
Long-term exposure to fine particulate matter, a type of air pollution, accelerates the decline in lung function among people with…
Routine blood tests can accurately predict the development of an allergic response to the fungus Aspergillus in children with…
Children with cystic fibrosis (CF) have lower gut levels of certain short-chain fatty acids (SCFAs), metabolites made by beneficial…
Handgrip strength was associated with breathing muscle strength in adults with cystic fibrosis (CF), according to a new study,…
Packaging fat-soluble vitamins in orally available nanomicelles, or tiny vesicles that enhance drug delivery, improves absorption into the bloodstream…
Treatment with Kaftrio may reduce the need for salt supplementation to treat salt wasting, the excessive loss of sodium and…